LEVOTIROXINA GSK
|
GlaxoSmithKline Biopharma
|
levotiroxina |
Terapéutica tiroidea |
100 mcg comp.x 50 | $22.563,36 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.906,68 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $12.611,35 AF $9.952,01 |
|
|
|
|
112 mcg comp.x 50 | $25.403,98 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.543,20 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $14.272,12 AF $11.131,86 |
|
|
|
|
125 mcg comp.x 50 | $28.339,82 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.700,61 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.878,35 AF $12.461,47 |
|
|
|
|
137 mcg comp.x 50 | $30.612,90 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $2.951,75 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.124,69 AF $13.488,21 |
|
|
|
|
150 mcg comp.x 50 | $31.843,10 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.043,81 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $17.760,34 AF $14.082,76 |
|
|
|
|
175 mcg comp.x 50 | $36.718,86 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.390,20 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $20.517,89 AF $16.200,97 |
|
|
|
|
25 mcg comp.x 50 | $7.171,29 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.292,53 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $1.347,98 |
|
|
|
|
50 mcg comp.x 50 | $10.803,60 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.319,14 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $5.823,31 AF $4.980,29 |
|
|
|
|
75 mcg comp.x 50 | $15.144,02 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.659,88 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.538,77 AF $6.605,25 |
|
|
|
|
88 mcg comp.x 50 | $19.781,57 | (31/03/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.690,68 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.124,06 AF $8.657,51 |
|
|
|
|
|